
Three major pharmaceutical companies — Amgen Inc. (NASDAQ:AMGN), Eli Lilly and Co (NYSE:LLY), and UCB SA (OTC:UCBJY) (OTC:UCBJF) — are suing U.S. Secretary of Health and Human Services (HHS) Robert F. Kennedy Jr. over the way his department is handling a drug discount program.
What Happened: The companies allege that HHS cost them millions of dollars in losses due to improperly certifying ineligible clinics under Section 340B of the Public Health Service Act.